Product Code: GVR-4-68038-665-3
Cell Expansion Market Growth & Trends:
The global cell expansion market size is expected to reach USD 47.13 billion by 2030 registering a CAGR of 12.85%, according to a new report by Grand View Research, Inc.. Cell expansion techniques are increasingly employed for the development of cellular and gene therapies from a single cord blood collection. These techniques can also be used for the expansion of stored Stem Cells (SCs) for the development of cancer therapies. Therefore, significant developments in cord blood SCs expansion technologies are expected to boost market growth.
Companies have made heavy investments for the expansion of tissue-engineered products and the development of biologics. For instance, in March 2019, Merck KGaA invested USD 168 million for the expansion of its biologics manufacturing facility in Switzerland. Such initiatives are expected to boost the demand for solutions required for biologic development, thereby leading to market growth.
Bioreactors are fundamental tools in this market. Extensive research studies related to the applications of bioreactor engineering approaches have led to the incorporation of novel culture technologies. Moreover, the combined use of automated bioreactors with the microcarrier technology leads to an efficient expansion and enrichment of the cancer SCs. As a result, these approaches have gained immense traction in this market.
Cell Expansion Market Report Highlights:
- Broad portfolio of automated expansion systems along with improvements in bioreactor design for large-scale bioproduction results in the lucrative growth opportunity for instruments
- The microbial cells segment is expected to witness the fastest growth rate owing to the implementation of high-throughput cultivation approaches and techniques that avoid the formation of biofilms
- Biopharmaceuticals segment held the largest revenue share in 2022 due to growth in the demand for biosimilars, continuous R&D investments in biomanufacturing, and rise in the number of approvals for biologics
- Asia Pacific is expected to witness the fastest CAGR from 2023 to 2030 due to presence of several consortiums that focus on the evolving fields in the biomedical industry
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Cell type
- 1.1.3. Application
- 1.1.4. End use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product
- 2.2.2. Cell Type outlook
- 2.2.3. Application outlook
- 2.2.4. End use outlook
- 2.2.5. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Cell Expansion Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Cell Expansion Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's Five Forces
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Cell Expansion Market: Product Estimates & Trend Analysis
- 4.1. Cell Expansion Market: Key Takeaways
- 4.2. Cell Expansion Market: Product Movement & Market Share Analysis, 2022 & 2030
- 4.3. Consumables
- 4.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.2. Reagents, media & serum
- 4.3.2.1. Reagents, media & serum market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.3. Other consumables
- 4.3.3.1. Other consumables market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Cultural flasks and accessories
- 4.4.1. Cultural flasks and accessories market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Tissue culture flasks
- 4.4.2.1. Tissue culture flasks market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Bioreactor accessories
- 4.4.3.1. Bioreactor accessories market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.4. Other culture flasks and accessories
- 4.4.4.1. Other culture flasks and accessories market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Instruments
- 4.5.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.2. Automated cell expansion systems
- 4.5.2.1. Automated cell expansion systems market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.3. Cell counters
- 4.5.3.1. Cell counters market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.4. Centrifuges
- 4.5.4.1. Centrifuges market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.5. Bioreactors
- 4.5.5.1. Bioreactors market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.6. Other instruments
- 4.5.6.1. Other instruments market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cell Expansion Market: Cell Type Estimates & Trend Analysis
- 5.1. Cell Expansion Market: Key Takeaways
- 5.2. Cell Expansion Market: Cell Type Movement & Market Share Analysis, 2022 & 2030
- 5.3. Mammalian cells
- 5.3.1. Mammalian cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.2. Human cells
- 5.3.2.1. Human cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.2.2. Stem cells
- 5.3.2.2.1. Stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.2.2.2. Adult stem cells
- 5.3.2.2.2.1. Adult cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.2.2.3. Induced pluripotent stem cells
- 5.3.2.2.3.1. Induced pluripotent stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.2.2.4. Embryonic stem cells
- 5.3.2.2.4.1. Embryonic stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.2.3. Differentiated cells
- 5.3.2.3.1. Differentiated cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.3. Animal cells
- 5.3.3.1. Animal cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Microbial cells
- 5.4.1. Microbial cells market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Others
- 5.5.1. Other cell types market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cell Expansion Market: Application Estimates & Trend Analysis
- 6.1. Cell Expansion Market: Key Takeaways
- 6.2. Cell Expansion Market: Application Movement & Market Share Analysis, 2022 & 2030
- 6.3. Biopharmaceuticals
- 6.3.1. Biopharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4. Tissue culture & engineering
- 6.4.1. Tissue culture & engineering market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Vaccine production
- 6.5.1. Vaccine production market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Drug development
- 6.6.1. Drug development market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7. Gene therapy
- 6.7.1. Gene therapy market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.8. Cancer research
- 6.8.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.9. Stem cell research
- 6.9.1. Stem cell research market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.10. Other applications
- 6.10.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Cell Expansion Market: End Use Estimates & Trend Analysis
- 7.1. Cell Expansion Market: Key Takeaways
- 7.2. Cell Expansion Market: End-use Movement & Market Share Analysis, 2022 & 2030
- 7.3. Biotechnology & biopharmaceutical companies
- 7.3.1. Biotechnology & biopharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4. Research institutes
- 7.4.1. Research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5. Cell banks
- 7.5.1. Cell banks market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6. Others
- 7.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Cell Expansion Market: Regional Estimates & Trend Analysis
- 8.1. Regional Outlook
- 8.2. Cell Expansion Market by Region: Key Marketplace Takeaways
- 8.3. North America
- 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.3.3. Canada
- 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4. Europe
- 8.4.1. UK
- 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.2. Germany
- 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.3. France
- 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.4. Italy
- 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.5. Spain
- 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.6. Denmark
- 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.7. Sweden
- 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.4.8. Norway
- 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5. Asia Pacific
- 8.5.1. Japan
- 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.2. China
- 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.3. India
- 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.4. Australia
- 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.5. Thailand
- 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.5.6. South Korea
- 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6. Latin America
- 8.6.1. Brazil
- 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.2. Mexico
- 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7. MEA
- 8.7.1. South Africa
- 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.2. Saudi Arabia
- 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.3. UAE
- 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 8.7.4. Kuwait
- 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.2.1. Thermo Fisher Scientific, Inc.
- 9.2.1.1. Company overview
- 9.2.1.2. Financial performance
- 9.2.1.3. Product benchmarking
- 9.2.1.4. Strategic initiatives
- 9.2.2. GE Healthcare
- 9.2.2.1. Company overview
- 9.2.2.2. Financial performance
- 9.2.2.3. Product benchmarking
- 9.2.2.4. Strategic initiatives
- 9.2.3. Corning Incorporated
- 9.2.3.1. Company overview
- 9.2.3.2. Financial performance
- 9.2.3.3. Product benchmarking
- 9.2.3.4. Strategic initiatives
- 9.2.4. Merck KGaA
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. Miltenyi Biotec
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. BD (Becton, Dickinson and Company)
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. TERUMO BCT, INC.
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. Sartorius AG
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. Takara Bio Inc.
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. TRINOVA BIOCHEM GmbH
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives
- 9.2.11. upcyte technologies GmbH
- 9.2.11.1. Company overview
- 9.2.11.2. Financial performance
- 9.2.11.3. Product benchmarking
- 9.2.11.4. Strategic initiatives